ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Hosts David and Gina enter the quantum realm to trace the evolution of this futuristic technology
Even with government support, firms in the US and Europe will struggle to catch up with China
These chiral fluorescent crystals were designed to thwart counterfeiting
Students from all fields lose out on tens of millions of dollars in career-boosting funds this year
As Pfizer pulls a candidate from the market, Lilly expects its pill to get approved next year
Already-approved grants were sent back for review, while 200 active ones may face termination
Students from all fields lose out on tens of millions of dollars in career-boosting funds this year
Canada and China both have reasons to lure top talent, but Europe’s sense of urgency runs higher
Even with government support, firms in the US and Europe will struggle to catch up with China
Already-approved grants were sent back for review, while 200 active ones may face termination
The US won’t be party to the global agreement that will allow for rapid sharing of pandemic-related information, pathogen samples, and genetic sequences
Drugmakers sort through many modalities to find the best match for their target proteins
The first scaled-up synthesis of this 9-sugar ring could expand its applications